TrialPediatric blood & cancer2013

PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report.

Stephen X Skapek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.